Role of crystallin racemization and isomerization in cataract
Role of crystallin racemization and isomerization in cataract
批准号:
9933672
负责人:
LARRY L DAVID
金额:
$4.33万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2022-08-31
关键词:
Amino AcidsAsparagineAspartateAspartic AcidBiophysicsCataractChemicalsCrystallinsDeuteriumDevelopmentGeneticHumanHydrogenIn VitroLaboratoriesLocationMass Spectrum AnalysisMeasuresModificationMutagenesisNMR SpectroscopyPeptidesPharmaceutical PreparationsPhysiologicalPlayPost-Translational Protein ProcessingProcessPropertyProtein BiosynthesisProtein DenaturationProteinsRecombinantsResearchResolutionRoleSiteStructural ProteinStructureTechniquesTestingTimeWorkage relatedagedalpha-Crystallinsdeamidationdrug discoveryexperimental studylenslight scatteringnephelometrynovelpreventprotein aggregationprotein structureprotein structure functionracemizationsynthetic protein
中文摘要
项目摘要
年龄相关性白内障与晶体蛋白的广泛脱酰胺、外消旋和异构化有关,
晶状体的主要屈光蛋白。我们的实验室和其他机构进行的广泛研究发现
脱酰胺化显著降低了晶体蛋白的稳定性,并对其结构造成极小的扰动。然而,
这些通过诱变产生的脱酰胺模拟物在体外不容易聚集。我们假设
这是因为它们缺乏外消旋和异构化,伴随着两个修饰
可能比单独的脱酰胺作用对晶体蛋白结构更具破坏性的脱酰胺作用。与去酰胺化不同,
这些修饰不能通过遗传手段引入晶体蛋白中。这阻止了研究
评估这些额外修饰在老年性白内障中的重要性。因此,其目的是
这些实验是为了创建γS-含有特定位置的生理相关的消旋和消旋的晶体蛋白
与年龄相关的脱酰亚胺过程中产生的异构化天冬氨酸及其对
蛋白质结构。具体目标是:1)使用合成重肽标准品和高分辨质量
分光光度法测定γS中不同外消旋和异构化天冬氨酸的相对比例
从老年性白内障人晶状体中提取晶体蛋白,以便相关物种
选择,2)将这些外消旋和异构化残基引入γS晶体中,采用半合成
以前从未在镜头领域中使用过的工艺,以及3)检查这些修改的结果
用蛋白质稳定性和光散射方法研究γS晶体结构,氢/氢
交换质谱学和核磁共振光谱学。这些实验将,对于
第一次,严格测试与年龄相关的消旋和异构化对结晶蛋白的潜在影响
结构。这些结果可以通过开发药物在减缓白内障发展方面发挥重要作用
特别防止老化晶状体中消旋化和异构化晶状体蛋白的聚集和光散射。
英文摘要
Project Summary
Age-related cataract is associated with extensive deamidation, racemization, and isomerization of crystallins,
the major refractive proteins of the lens. Extensive studies by our laboratories and others have found
deamidation significantly decreases the stability of crystallins with minimal structural perturbations. However,
these deamidation mimics created using mutagenesis did not readily aggregate in vitro. We hypothesize that
this is because they were lacking racemization and isomerization, two modifications accompanying
deamidation that may be more disruptive to crystallin structure than deamidation alone. Unlike deamidation,
these modifications cannot be introduced into crystallins by genetic means. This has prevented studies to
gauge the importance of these additional modifications in age-related cataract. Therefore, the purpose of
these experiments is to create γS-crystallins containing specific sites of physiologically relevant racemized and
isomerized aspartates that result from the age-related deamidation process and determine their effect on
protein structure. The specific aims are to: 1) use synthetic heavy peptide standards and high-resolution mass
spectrometry to determine the relative proportion of different racemized and isomerized aspartates in γS-
crystallin from the insoluble protein of aged cataractous human lenses so that relevant species can be
selected, 2) introduce these racemized and isomerized residues into γS-crystallin using semi-synthetic
processes that have never before been used in the lens field, and 3) examine the result of these modifications
on γS-crystallin structure using protein stability and light scattering measurements, hydrogen/deuterium
exchange mass spectrometry, and nuclear magnetic resonance spectroscopy. These experiments will, for the
first time, critically test the potential impact of age-related racemization and isomerization on crystallin
structure. These results could play an important role in slowing cataract development by developing drugs that
specifically prevent the aggregation and light scatter of racemized and isomerized crystallins in aged lenses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Orbitrap Tribrid Mass Spectrometer
-
批准号:10175686
-
项目类别:
-
资助金额:$110.14万
-
财政年份:2021
-
负责人:LARRY L DAVID
-
依托单位:
Role of crystallin racemization and isomerization in cataract
-
批准号:9752550
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2017
-
负责人:LARRY L DAVID
-
依托单位:
Role of crystallin racemization and isomerization in cataract
-
批准号:10011819
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2017
-
负责人:LARRY L DAVID
-
依托单位:
Role of crystallin racemization and isomerization in cataract
-
批准号:10242798
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2017
-
负责人:LARRY L DAVID
-
依托单位:
LTQ Orbitrap Velos
-
批准号:8333650
-
项目类别:
-
资助金额:$85.37万
-
财政年份:2012
-
负责人:LARRY L DAVID
-
依托单位:
LTQ XL Linear Ion Trap Mass Spectrometer
-
批准号:7595676
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2009
-
负责人:LARRY L DAVID
-
依托单位:
LINEAR ION TRAP MASS SPECTROMETER: CELL BIOLOGY
-
批准号:7166314
-
项目类别:
-
资助金额:$9.14万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
LINEAR ION TRAP MASS SPECTROMETER: KIDNEY
-
批准号:7166313
-
项目类别:
-
资助金额:$1.52万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
LINEAR ION TRAP MASS SPECTROMETER: EYE, VISION
-
批准号:7166311
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
Linear Ion Trap Mass Spectrometer
-
批准号:6876906
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
LINEAR ION TRAP MASS SPECTROMETER: CYSTIC FIBROSIS
-
批准号:7166312
-
项目类别:
-
资助金额:$1.52万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
CORE--PROTEOMICS
-
批准号:6949388
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2005
-
负责人:LARRY L DAVID
-
依托单位:
Core--Metal Ion Regulation /Transport
-
批准号:6591524
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2002
-
负责人:LARRY L DAVID
-
依托单位:
MASS SPECTROMETRIC ANALYSIS OF LENS PROTEINS
-
批准号:2451360
-
项目类别:
-
资助金额:$26.26万
-
财政年份:1998
-
负责人:LARRY L DAVID
-
依托单位:
MASS SPECTROMETRIC ANALYSIS OF LENS PROTEINS
-
批准号:2872383
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1998
-
负责人:LARRY L DAVID
-
依托单位:
MASS SPECTROMETRIC ANALYSIS OF LENS PROTEINS
-
批准号:6350868
-
项目类别:
-
资助金额:$12.7万
-
财政年份:1998
-
负责人:LARRY L DAVID
-
依托单位:
MASS SPECTROMETRIC ANALYSIS OF LENS PROTEINS
-
批准号:6151085
-
项目类别:
-
资助金额:$12.33万
-
财政年份:1998
-
负责人:LARRY L DAVID
-
依托单位:
Proteomics and Mass Spectrometry
-
批准号:10707535
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1997
-
负责人:LARRY L DAVID
-
依托单位:
Proteomics Shared Resource
-
批准号:10205355
-
项目类别:
-
资助金额:$27.09万
-
财政年份:1997
-
负责人:LARRY L DAVID
-
依托单位:
Proteomics and Mass Spectrometry
-
批准号:10250837
-
项目类别:
-
资助金额:$18.4万
-
财政年份:1997
-
负责人:LARRY L DAVID
-
依托单位:
国内基金
海外基金
TCA源性酰胺衍生物Asparagine维护抗LPO防御系统的机制及在抑制PTOA肌肉萎缩中的作用
-
批准号:82372495
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:倪振洪
-
依托单位: